Biotech

All Articles

Innovent hyperlinks cytokine to colorectal cancer cells responses

.Innovent Biologics has created the case that its checkpoint inhibitor-cytokine blend healthy protei...

Merck, Daiichi ADC hits objective in phase 3 lung cancer cells study

.A period 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC)...

Rakovina strengthens AI concentrate along with collab to select cancer cells aim ats

.5 months after Rakovina Rehabs rotated towards expert system, the cancer-focused biotech has joined...

Ascendis' dwarfism drug favorites in phase 3, intimidates BioMarin

.Ascendis Pharma has become a possible hazard to BioMarin's Voxzogo, reporting phase 3 growth condit...

Despite ph. 3 skip, Alkeus sees path ahead of time for eye disease asset

.Though Alkeus Pharmaceuticals' oral eye health condition resource stopped working to substantially ...

Kairos goes public with $6M IPO to fund tests of cancer cells medication

.Along with a trio of biotechs striking the Nasdaq on Friday, it was actually very easy to miss out ...

Vaccine and also Keytruda combination successful in squamous tissue cancer

.Immune system gate inhibitors are actually the superheroes of cancer cells treatment. Medications l...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant management hirings, shootings...

Regeneron's Opdualag opponent shows 57% action cost

.Regeneron is back with long-lasting follow-up for its LAG-3 inhibitor and also PD-1 inhibitor combo...

AstraZeneca blog posts records on in-house opponents to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed an early consider the efficiency of its in-house antibody-drug c...